A Prospective, Open Label, Multicenter Trial for Evaluating the Efficacy of Treating and Managing Wounds in Elderly Population in Specialized Nursing Facilities Using RD1

Inclusion Criteria: * Subject is ≥18 years of age * Patient with a wound deemed suitable for treatment with RD1 * Ulcer free of clinical signs of infection. * Post-debridement, ulcer free of necrotic tissue. * For foot ulcers, Subject has adequate vascular perfusion of the affected limb, as defined by - Ankle-Brachial Index (ABI) ≥ 0.65 and ≤ 1.2 * HbA1c ≤ 12.0% (diabetic patients) * Subject or legal authorized representative must be willing to comply with the protocol including having blood drawn to create the RD1. * Female subjects who are capable of conceiving must use an acceptable form of contraception in order to participate in the study (acceptable forms of contraception include condoms for males and contraceptive pills or IUDs for women). Exclusion Criteria: * If ulcer area decreases by ≥ 30% during the initial 2-week screening (± 2 days) and standard of care phase, or if the ulcer area increases ≥ 30%, * Presence of active underlying osteomyelitis. * Patient with a proven sepsis established by a blood culture in the past 2 weeks, or confirmed active infection likely to interfere with trial, such as urine tract infection * Known malignancy in the reference wound bed or margins of the wound * Exposure of blood vessels or organs at the base of the reference wound * History of alcohol or substance abuse, within the previous 2 months * Subject has participated in another clinical trial involving a device or a systemically administered investigational study drug or trea…